Piramal Pharma Ltd 10 Apr 2024 12:00 AM
Piramal Pharma forays into men`s grooming market in India with launch of BOHEM,
Piramal Pharma announced its foray into men`s personal grooming category with the launch of BOHEM product range. This includes a Hair Removal Spray, a Beard Growth Oil, and an Underarm Roll-On. With BOHEM, Piramal Pharma intends to shift the grooming culture among men towards more inclusive self-care routines, leveraging scientifically proven ingredients for tangible results.Powered by Capital Market - Live News
Piramal Pharma Ltd 31 Jan 2024 12:00 AM
Piramal Pharma reports standalone net profit of Rs 74.34 crore in the December 2023 quarter,
Net profit of Piramal Pharma reported to Rs 74.34 crore in the quarter ended December 2023 as against net loss of Rs 2.42 crore during the previous quarter ended December 2022. Sales rose 25.93% to Rs 1024.14 crore in the quarter ended December 2023 as against Rs 813.29 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales1024.14813.29 26 OPM %12.263.35 - PBDT141.2247.93 195 PBT89.660.74 12016 NP74.34-2.42 LP Powered by Capital Market - Live News
Piramal Pharma Ltd 31 Jan 2024 12:00 AM
Piramal Pharma reports consolidated net profit of Rs 10.11 crore in the December 2023 quarter,
Net profit of Piramal Pharma reported to Rs 10.11 crore in the quarter ended December 2023 as against net loss of Rs 90.18 crore during the previous quarter ended December 2022. Sales rose 14.14% to Rs 1958.57 crore in the quarter ended December 2023 as against Rs 1715.97 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales1958.571715.97 14 OPM %13.705.09 - PBDT237.9590.79 162 PBT51.63-73.64 LP NP10.11-90.18 LP Powered by Capital Market - Live News
Piramal Pharma Ltd 18 Jan 2024 12:00 AM
Piramal Pharma to convene board meeting,
Piramal Pharma will hold a meeting of the Board of Directors of the Company on 30 January 2024.Powered by Capital Market - Live News
Piramal Pharma Ltd 09 Nov 2023 12:00 AM
Piramal Pharma`s Bethlehem unit clears USFDA inspection,
Piramal Pharma announced that the USFDA has issued an Establishment Inspection Report (EIR) for the company`s manufacturing unit located at Bethlehem, USA and the inspection has now been successfully closed by the USFDA. Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now